Edecrin Sodium and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Edecrin Sodium and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethacrynic acid
Brand name: Sodium Edecrin, Edecrin, Edecrin Sodium
Synonyms: Sodium Edecrin
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Edecrin Sodium-Moxifloxacin
- Edecrin Sodium-Moxifloxacin (Systemic)
- Edecrin Sodium-Moxifloxacin Hydrochloride
- Edecrin Sodium-Moxifloxacin Injection
- Edecrin Sodium-Moxifloxacin Intravenous
- Edecrin Sodium-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Edetate calcium disodium
- Moxetumomab pasudotox-tdfk Intravenous-Edex
- Moxetumomab pasudotox-tdfk Intravenous-Edex Injection
- Moxetumomab pasudotox-tdfk Intravenous-Edluar
- Moxetumomab pasudotox-tdfk Intravenous-Edoxaban
- Moxetumomab pasudotox-tdfk Intravenous-Edoxaban Tosylate